Lithium – past, present, future

References

• Adli M, Hollinde DL, Stamm T, Wiethoff K, Tsahuridu M, Kirchheiner J, Heinz A, Bauer M. 2007. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol Psychiatry. 62(11):1295–1302. doi:10.1016/j.biopsych.2007.03.023
   PubMed Web of Science ®Google Scholar
• Altamura AC, Mundo E, Dell'Osso B, Tacchini G, Buoli M, Calabrese JR. 2008. Quetiapine and classical mood stabilizers in the long-term treatment of bipolar disorder: a 4-year follow-up naturalistic study. J Affect Disord. 110(1–2):135–141. doi:10.1016/j.jad.2008.01.017
   PubMed Web of Science ®Google Scholar
• Baastrup PC. 1964. The use of lithium in manic-depressive psychoses. Compr Psychiatry. 5(6):396–408. doi:10.1016/S0010-440X(64)80049-3
   PubMed Web of Science ®Google Scholar
• Baastrup PC, Schou M. 1967. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry. 16(2):162–172. doi:10.1001/archpsyc.1967.01730200030005
   PubMed Web of Science ®Google Scholar
• Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M. 2014. Role of lithium augmentation in the management of major depressive disorder. CNS Drugs. 28(4):331–342. doi:10.1007/s40263-014-0152-8
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. 2006. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 8(5p2):625–639. doi:10.1111/j.1399-5618.2006.00344.x
   PubMedGoogle Scholar
• Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. 2007. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv. 58(1):85–91. doi:10.1176/ps.2007.58.1.85
   PubMed Web of Science ®Google Scholar
• Berk M, Dandash O, Daglas R, Cotton SM, Allott K, Fornito A, Suo C, Klauser P, Liberg B, Henry L, et al. 2017. Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume. Transl Psychiatry. 7(1):e1011–e1011. doi:10.1038/tp.2016.281
   PubMedGoogle Scholar
• Blackwell B, Shepherd M. 1968. Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet. 291(7549):968–971. doi:10.1016/S0140-6736(68)90917-3
   Google Scholar
• Blüml V, Regier MD, Hlavin G, Rockett IRH, König F, Vyssoki B, Bschor T, Kapusta ND. 2013. Lithium in the public water supply and suicide mortality in Texas. J Psychiatr Res. 47(3):407–411. doi:10.1016/j.jpsychires.2012.12.002
   PubMed Web of Science ®Google Scholar
• Brown KM, Tracy DK. 2013. Lithium: the pharmacodynamic actions of the amazing ion. Ther Adv Psychopharmacol. 3(3):163–176. doi:10.1177/2045125312471963
   PubMedGoogle Scholar
• Cade JFK. 1949. Lithium salts in the treatment of psychotic excitement. Med J Aust. 2(10):349–352. doi:10.5694/j.1326-5377.1949.tb36912.x
   PubMed Web of Science ®Google Scholar
• Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Purgato M, Spineli LM, Goodwin GM, Geddes JR. 2011. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 378(9799):1306–1315. doi:10.1016/S0140-6736(11)60873-8
   PubMed Web of Science ®Google Scholar
• Cipriani A, Hawton K, Stockton S, Geddes JR. 2013. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 346:f3646. doi:10.1136/bmj.f3646
   PubMed Web of Science ®Google Scholar
• Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. 1991. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord. 23(1):1–7. doi:10.1016/0165-0327(91)90030-V
   PubMed Web of Science ®Google Scholar
• Costa L. d S, Alencar ÁP, Nascimento Neto PJ, dos Santos M. d S V, da Silva CGL, Pinheiro S. d F L, Silveira RT, Bianco BAV, Pinheiro RFF, de Lima MAP, et al. 2015. Risk factors for suicide in bipolar disorder: a systematic review. J Affect Disord. 170:237–254. doi:10.1016/j.jad.2014.09.003
   PubMed Web of Science ®Google Scholar
• Crossley NA, Bauer M. 2007. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 68: 935–940.
   Google Scholar
• Dandash O, Yücel M, Daglas R, Pantelis C, McGorry P, Berk M, Fornito A. 2018. Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania. Transl Psychiatry. 8(1):59. doi:10.1038/s41398-018-0108-8
   PubMedGoogle Scholar
• De Montigny C, Grunberg F, Mayer A, Deschenes JP. 1981. Lithium induces rapid relief of depression in tricyclic antidepressant nonresponders. Br J Psychiatry. 138(3):252–256. doi:10.1192/bjp.138.3.252
   PubMedGoogle Scholar
• Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH. 2004. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry. 55(6):588–593. doi:10.1016/j.biopsych.2003.10.008
   PubMed Web of Science ®Google Scholar
• Donix M, Bauer M. 2016. Population studies of association between lithium and risk of neurodegenerative disorders. Curr Alzheimer Res. 13(8):873–878. doi:10.2174/1567205013666160219112957
   PubMed Web of Science ®Google Scholar
• Fajardo VA, Fajardo VA, LeBlanc PJ, MacPherson REK. 2017. Examining the relationship between trace lithium in drinking water and the rising rates of age-adjusted Alzheimer’s disease mortality in Texas. JAD. 61(1):425–434. doi:10.3233/JAD-170744
   Google Scholar
• Ferensztajn-Rochowiak E, Kucharska-Mazur J, Tarnowski M, Samochowiec J, Ratajczak MZ, Rybakowski JK. 2018. Stem cells, pluripotency and glial cell markers in peripheral blood of bipolar patients on long-term lithium treatment. Prog Neuropsychopharmacol Biol Psychiatry. 80(Pt A):28–33. doi:10.1016/j.pnpbp.2017.06.013
   PubMedGoogle Scholar
• Focosi D, Azzarà A, Kast RE, Carulli G, Petrini M. 2009. Lithium and hematology: established and proposed uses. J Leukoc Biol. 85(1):20–28. doi:10.1189/jlb.0608388
   PubMed Web of Science ®Google Scholar
• Franchini L, Zanardi R, Smeraldi E, Gasperini M. 1999. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci. 249(5):227–230. doi:10.1007/s004060050091
   PubMed Web of Science ®Google Scholar
• Garrod AB. 1859. Gout and rheumatic gout. London: Walton and Maberly.
   Google Scholar
• Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. 2004. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 161(2):217–222. doi:10.1176/appi.ajp.161.2.217
   PubMed Web of Science ®Google Scholar
• Germaná C, Kempton MJ, Sarnicola A, Christodoulou T, Haldane M, Hadjulis M, Girardi P, Tatarelli R, Frangou S. 2010. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand. 122(6):481–487. doi:10.1111/j.1600-0447.2010.01582.x
   PubMed Web of Science ®Google Scholar
• Gillis A. 1983. Lithium in herpes simplex. Lancet. 321:516.
   Google Scholar
• Giotakos O, Nisianakis P, Tsouvelas G, Giakalou VV. 2013. Lithium in the public water supply and suicide mortality in Greece. Biol Trace Elem Res. 156(1-3):376–399. doi:10.1007/s12011-013-9815-4
   PubMed Web of Science ®Google Scholar
• Grof P. 1999. Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW, editors. Lithium: 50 years of psychopharmacology, new perspectives in biomedical and clinical research. Cheshire, Connecticut: Weidner Publishing Group; p. 36–51.
   Google Scholar
• Gitlin M. 2016. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord 4: 27.
   Google Scholar
• Grof P. 2010. Sixty years of lithium responders. Neuropsychobiology. 62(1):8–35. doi:10.1159/000314305
   PubMed Web of Science ®Google Scholar
• Hajek T, Bauer M, Simhandl C, Rybakowski J, O'Donovan C, Pfennig A, König B, Suwalska A, Yucel K, Uher R, et al. 2014. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med. 44(3):507–517. doi:10.1017/S0033291713001165
   PubMed Web of Science ®Google Scholar
• Hajek T, Weiner MW. 2016. Neuroprotective effects of lithium in human brain? Food for thought. Curr Alzheimer Res. 13(8):862–872. doi:10.2174/1567205013666160219112712
   PubMed Web of Science ®Google Scholar
• Hammond WA. 1871. Treatise on diseases of the nervous system. New York: Appleton.
   Google Scholar
• Hartigan G. 1963. The use of lithium salts in affective disorders. Br J Psychiatry. 109:810–814. doi:10.1192/bjp.109.463.810
   PubMed Web of Science ®Google Scholar
• Hayes J, Prah P, Nazareth I, King M, Walters K, Petersen I, Osborn D. 2011. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PLoS One. 6(12):e28725doi:10.1371/journal.pone.0028725
   PubMed Web of Science ®Google Scholar
• Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM, et al. 2016. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 387(10023):1085–1093. doi:10.1016/S0140-6736(16)00143-4
   PubMed Web of Science ®Google Scholar
• Huang RY, Hsieh KP, Huang WW, Yang YH. 2016. Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Br J Psychiatry. 209(5):393–399. doi:10.1192/bjp.bp.116.181362
   PubMed Web of Science ®Google Scholar
• Hui TP, Kandola A, Shen L, Lewis G, Osborn DPJ, Geddes JR, Hayes JF. 2019. A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder. Acta Psychiatr Scand. 140(2):94–115. doi:10.1111/acps.13062
   PubMed Web of Science ®Google Scholar
• Itzhaki RF. 2018. Corroboration of a major role for herpes simplex virus type 1 in Alzheimer’s disease. Front Aging Neurosci. 10:324. doi:10.3389/fnagi.2018.00324
   PubMed Web of Science ®Google Scholar
• Jope RS. 2011. Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci. 4:16doi:10.3389/fnmol.2011.00016
   PubMed Web of Science ®Google Scholar
• Kapusta ND, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, Praschak-Rieder N, Sonneck G, Leithner-Dziubas K. 2011. Lithium in drinking water and suicide mortality. Br J Psychiatry. 198(5):346–350. doi:10.1192/bjp.bp.110.091041
   PubMed Web of Science ®Google Scholar
• Karanti A, Kardell M, Lundberg U, Landén M. 2016. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord. 195:50–56. doi:10.1016/j.jad.2016.01.043
   PubMed Web of Science ®Google Scholar
• Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M. 2012. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. Curr Med Res Opin. 28(5):701–713. doi:10.1185/03007995.2012.666961
   PubMed Web of Science ®Google Scholar
• Kessing LV, Sondergard L, Forman JL, Andersen PK. 2008. Lithium treatment and risk of dementia. Arch Gen Psychiatry. 65(11):1331–1335. doi:10.1001/archpsyc.65.11.1331
   PubMed Web of Science ®Google Scholar
• Kessing LV, Forman JL, Andersen PK. 2010. Does lithium protect against dementia? Bipolar Disord. 12:97–94.
   Web of Science ®Google Scholar
• Kessing LV, Vradi E, Andersen PK. 2014. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry. 205(3):214–220. doi:10.1192/bjp.bp.113.142802
   PubMed Web of Science ®Google Scholar
• Kessing LV, Vradi E, Andersen PK. 2016. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 18(2):174–182. doi:10.1111/bdi.12371
   PubMed Web of Science ®Google Scholar
• Kessing LV, Gerds TA, Knudsen NN, Jørgensen LF, Kristiansen SM, Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, et al. 2017. Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry. 74(10):1005–1010. doi:10.1001/jamapsychiatry.2017.2362
   PubMed Web of Science ®Google Scholar
• Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. 2018. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord. 20(5):419–431. doi:10.1111/bdi.12623
   Web of Science ®Google Scholar
• Kliwicki S, Chłopocka-Woźniak M, Rudnicka E, Rybakowski J. 2014. Efficacy of long-term lithium treatment in bipolar affective illness (in Polish). Pharmakother Psychiatry Neurol. 30:5–13.
   Google Scholar
• Kraepelin E. 1899. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 6 Auflage. Leipzig: Barth.
   Google Scholar
• Kraszewska A, Ziemnicka K, Jończyk-Potoczna K, Sowiński J, Rybakowski JK. 2019a. Thyroid structure and function in long-term lithium-treated and lithium-naïve bipolar patients. Hum Psychopharmacol. 34(4):e2708doi:10.1002/hup.2708
   PubMed Web of Science ®Google Scholar
• Kraszewska A, Ziemnicka K, Sowiński J, Ferensztajn-Rochowiak E, Rybakowski JK. 2019b. No connection between long-term lithium treatment and antithyroid antibodies. Pharmacopsychiatry. 52(5):232–236. doi:10.1055/a-0838-6062
   PubMed Web of Science ®Google Scholar
• Lange C. 1886. Om Periodiske Depressionstilstande og deres Patogenese. Lund, Copenhagen.
   Google Scholar
• Lähteenvuo M, Tanskanen A, Taipale H, Hoti F, Vattulainen P, Vieta E, Tiihonen J. 2018. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry. 75(4):347–355. doi:10.1001/jamapsychiatry.2017.4711
   PubMed Web of Science ®Google Scholar
• Lewitzka U, Severus E, Bauer R, Ritter P, Müller-Oerlinghausen B, Bauer M. 2015. The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review. Int J Bipolar Disord. 3(1):32. doi:10.1186/s40345-015-0032-2
   PubMed Web of Science ®Google Scholar
• Lieb J. 1979. Remission of recurrent herpes infection during therapy with lithium. N Engl J Med. 301:942.
   PubMed Web of Science ®Google Scholar
• López-Jaramillo C, Lopera-Vásquez J, Ospina-Duque J, García J, Gallo A, Cortez V, Palacio C, Torrent C, Martínez-Arán A, Vieta E, et al. 2010. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry. 71(8):1055–1060. doi:10.4088/JCP.08m04673yel
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, Renshaw PF. 2010. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology. 35(8):1743–1750. doi:10.1038/npp.2010.41
   PubMed Web of Science ®Google Scholar
• Manchia M, Adli M, Akula N, Ardau R, Aubry J-M, Backlund L, Banzato CE, Baune BT, Bellivier F, Bengesser S, et al. 2013. Assessment of response to lithium maintenance treatment in bipolar disorder: a Consortium on Lithium Genetics (ConLiGen) report. PLoS One. 8(6):e65636. doi:10.1371/journal.pone.0065636
   PubMed Web of Science ®Google Scholar
• Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R. 2011. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord. 13(2):133–144. doi:10.1111/j.1399-5618.2011.00898.x
   PubMed Web of Science ®Google Scholar
• Matsunaga S, Kishi T, Annas P, Basun H, Hampel H, Iwata N. 2015. Lithium as a treatment for Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 48(2):403–410. doi:10.3233/JAD-150437
   PubMed Web of Science ®Google Scholar
• Mendels J. 1976. Lithium in the treatment of depression. Am J Psychiatry. 133(4):373–378. doi:10.1176/ajp.133.4.373
   PubMed Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Menji HK. 2000. Lithium-induced increase in human brain grey matter. Lancet. 356(9237):1241–1242. doi:10.1016/S0140-6736(00)02793-8
   PubMed Web of Science ®Google Scholar
• Morris G, Berk M. 2016. The putative use of lithium in Alzheimer's disease. Curr Alzheimer Res. 13(8):853–861. doi:10.2174/1567205013666160219113112
   PubMed Web of Science ®Google Scholar
• Munk-Olsen T, Liu X, Viktorin A, Brown HK, Di Florio A, D'Onofrio BM, Gomes T, Howard LM, Khalifeh H, Krohn H, et al. 2018. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. Lancet Psychiatry. 5(8):644–652. doi:10.1016/S2215-0366(18)30180-9
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R. 1992. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand. 86(3):218–222. doi:10.1111/j.1600-0447.1992.tb03255.x
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R, et al. 1994. Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated patients. Acta Psychiatr Scand. 90(4):295–297. doi:10.1111/j.1600-0447.1994.tb01596.x
   PubMed Web of Science ®Google Scholar
• Nassar A, Azab AN. 2014. Effects of lithium on inflammation. ACS Chem Neurosci. 5(6):451–458. doi:10.1021/cn500038f
   PubMed Web of Science ®Google Scholar
• Nivoli AMA, Murru A, Vieta E. 2010. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology. 62(1):27–35. doi:10.1159/000314307
   PubMed Web of Science ®Google Scholar
• Noack CH, Trautner EM. 1951. The lithium treatment of maniacal psychosis. Med J Aust. 2(7):219–222. doi:10.5694/j.1326-5377.1951.tb68249.x
   PubMedGoogle Scholar
• Nunes MA, Viel TA, Buck HS. 2013. Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. Curr Alzheimer Res. 10(1):104–107. doi:10.2174/1567205011310010014
   PubMed Web of Science ®Google Scholar
• Ohgami H, Terao T, Shiotsuki I, Ishii N, Iwata N. 2009. Lithium levels in drinking water and risk of suicide. Br J Psychiatry. 194(5):464–465. doi:10.1192/bjp.bp.108.055798
   PubMed Web of Science ®Google Scholar
• Palacios J, Yildiz A, Young AH, Taylor MJ. 2019. Tamoxifen for bipolar disorder: systematic review and meta-analysis. J Psychopharmacol (Oxford). 33(2):177–184. doi:10.1177/0269881118822167
   PubMed Web of Science ®Google Scholar
• Permoda-Osip A, Abramowicz M, Kraszewska A, Suwalska A, Chlopocka-Wozniak M, Rybakowski JK. 2016. Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients. Ther Adv Psychopharmacol. 6(4):277–282. doi:10.1177/2045125316643299
   PubMed Web of Science ®Google Scholar
• Poolsup N, Li Wan Po A, de Oliveira IR. 2000. Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther. 25(2):139–156. doi:10.1046/j.1365-2710.2000.00278.x
   PubMed Web of Science ®Google Scholar
• Post RM. 2018. The new news about lithium: an underutilized treatment in the United States. Neuropsychopharmacology. 43(5):1174–1179. doi:10.1038/npp.2017.238
   PubMed Web of Science ®Google Scholar
• Radomski J, Fuyat HN, Nelson AA, Smith PK. 1950. The toxic effects, excretion and distribution of lithium chloride. J Pharmacol Exp Ther. 100(4:1):429–440.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Amsterdam JD. 1991. Lithium prophylaxis and recurrent labial herpes infections. Lithium 2: 43–47.
   Google Scholar
• Rybakowski JK. 2000. Antiviral and immunomodulatory effect of lithium. Pharmacopsychiatry. 33(5):159–164.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2007. Two generations of mood stabilizers. Int J Neuropsychopharmacol. 10(5):709–711. doi:10.1017/s146114570700795x
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2014. Response to lithium in bipolar disorder: clinical and genetic findings. ACS Chem Neurosci. 5(6):413–421. doi:10.1021/cn5000277
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2016. Effect of lithium on neurocognitive functioning. Curr Alzheimer Res. 13(8):887–893. doi:10.2174/1567205013666160415154701
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2018a. Challenging the negative perception of lithium and optimizing its long-term administration. Front Mol Neurosci. 11:349. doi:10.3389/fnmol.2018.00349
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2018b. Meaningful aspects of the term ‘mood stabilizer’. Bipolar Disord. 20(4):391–392. doi:10.1111/bdi.12608
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2019. Commentary: Corroboration of a major role for herpes simplex virus type 1 in Alzheimer’s disease. Front Aging Neurosci. 10:433. doi:10.3389/fnagi.2018.00433
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Borkowska A, Skibinska M, Hauser J. 2006. Illness-specific association of Val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol Psychiatry. 11(2):122–124. doi:10.1038/sj.mp.4001765
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Checinska K. 2018. The use of lithium in Poland in 2004-2017. Pharmacother Psychiatry Neurol. 34:85–94.
   Google Scholar
• Rybakowski J, Chłopocka M, Lisowska J, Czerwiński A. 1974. The study on the efficacy of lithium in endogenous depressive syndromes (in Polish). Psychiatr Pol. 8:129–135.
   PubMedGoogle Scholar
• Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. 2001. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord. 3(2):63–67. doi:10.1034/j.1399-5618.2001.030203.x
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Dmitrzak-Weglar M, Kliwicki S, Hauser J. 2014. Polymorphism of circadian clock genes and prophylactic lithium response. Bipolar Disord. 16(2):151–158. doi:10.1111/bdi.12136
   PubMed Web of Science ®Google Scholar
• Rybakowski J, Matkowski K. 1992. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation. Eur Neuropsychopharmacol. 2(2):161–165. doi:10.1016/0924-977X(92)90027-6
   PubMedGoogle Scholar
• Rybakowski JK, Permoda-Osip A, Borkowska A. 2009. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol. 19(11):791–795. doi:10.1016/j.euroneuro.2009.06.002
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A. 2010. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol. 13(5):617–622. doi:10.1017/S1461145710000404
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2013. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. CNS Drugs 27: 165–173.
   Google Scholar
• Rybakowski JK, Suwalska A, Hajek T. 2018. Clinical perspectives of lithium's neuroprotective effect. Pharmacopsychiatry. 51(5):194–199. doi:10.1055/s-0043-124436
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, Czerski PM, Hauser J. 2005. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry. 38(4):166–170. doi:10.1055/s-2005-871239
   PubMed Web of Science ®Google Scholar
• Rybakowski J, Cubała WJ, Gałecki P, Rymaszewska J, Samochowiec J, Szulc A, Dudek D. 2019. Recommendations of the Polish Psychiatric Association regarding the treatment of affective disorders in women of childbearing age. Part II: Bipolar disorder. Psychiatr Pol. 53(2):263–276. doi:10.12740/PP/103555
   PubMed Web of Science ®Google Scholar
• Schou M, Juel-Nielsen N, Stromgren E, Voldby H. 1954. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 17(4):250–260. doi:10.1136/jnnp.17.4.250
   PubMed Web of Science ®Google Scholar
• Schou M, Thompsen K. 1975. Lithium prophylaxis of recurrent endogenous affective disorders. In: Johnson FN, editor. Lithium research and therapy. London: Academic Press; p. 63–84.
   Google Scholar
• Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ET, Chillotti C, Cichon S, Czerski P, Del Zompo M, et al. 2010. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology. 62(1):72–78. doi:10.1159/000314708
   PubMed Web of Science ®Google Scholar
• Scott J, Hidalgo-Mazzei D, Strawbridge R, Young A, Resche-Rigon M, Etain B, Andreassen OA, Bauer M, Bennabi D, Blamire AM, et al. 2019. Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative. Int J Bipolar Disord. 7(1):20. doi:10.1186/s40345-019-0156-x
   PubMed Web of Science ®Google Scholar
• Severus E, Bauer M. 2013. Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders. BMC Med. 11:34. doi:10.1186/1741-7015-11-34
   PubMed Web of Science ®Google Scholar
• Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, Geddes JR. 2014. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2:15. doi:10.1186/s40345-014-0015-8
   PubMedGoogle Scholar
• Skinner GRB, Hartley C, Buchan A, Harper L, Gallimore P. 1980. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol. 168(2):139–265. doi:10.1007/BF02121762
   PubMed Web of Science ®Google Scholar
• Souza FG, Goodwin GM. 1991. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry. 158:666–675. doi:10.1192/bjp.158.5.666
   PubMed Web of Science ®Google Scholar
• Stambolic V, Ruel L, Woodgett JR. 1996. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol. 6(12):1664–1668. doi:10.1016/S0960-9822(02)70790-2
   PubMed Web of Science ®Google Scholar
• Stephenson CP, Karanges E, McGregor IS. 2013. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry. 47(1):74–87. doi:10.1177/0004867412466595
   PubMed Web of Science ®Google Scholar
• Storosum JG, Wohlfarth T, Schene A, Elferink A, van Zwieten BJ, van den Brink W. 2007. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. Bipolar Disord. 9(8):793–798. doi:10.1111/j.1399-5618.2007.00445.x
   PubMed Web of Science ®Google Scholar
• Suppes T, Vieta E, Gustafsson U, Ekholm B. 2013. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Depress Anxiety. 30(11):1089–1098. doi:10.1002/da.22136
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M. 2017. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiatry. 4(7):547–553. doi:10.1016/S2215-0366(17)30134-7
   PubMed Web of Science ®Google Scholar
• Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, Calkin CV, Chillotti C, Hidalgo-Mazzei D, Manchia M, et al. 2017. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord. 5(1):27. doi:10.1186/s40345-017-0096-2
   PubMedGoogle Scholar
• Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, Lewitka U, Licht RW, Manchia M, Müller-Oerlinghausen B, et al. 2019. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 7(1):16. doi:10.1186/s40345-019-0151-2
   PubMedGoogle Scholar
• Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ. 2019. Lithium treatment for unipolar major depressive disorder: systematic review. J Psychopharmacol. 33(2):167–176. doi:10.1177/0269881118822161
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. 2005. Reduced relative risk of fractures among users of lithium. Calcif Tissue Int. 77(1):1–8. doi:10.1007/s00223-004-0258-y
   PubMed Web of Science ®Google Scholar
• Williams R, Ryves WJ, Dalton EC, Eickholt B, Shaltiel G, Agam G, Harwood AJ. 2004. A molecular cell biology of lithium. Biochem Soc Trans. 32 (Pt 5):799–802. doi:10.1042/BST0320799
   PubMedGoogle Scholar
• Zamani A, Omrani GR, Nasab MM. 2009. Lithium’s effect on bone mineral density. Bone. 44(2):331–334. doi:10.1016/j.bone.2008.10.001
   PubMedGoogle Scholar